Literature DB >> 30532875

A case of coronary artery disease with antiphospholipid syndrome that showed repeated stent thrombosis.

Takahiro Mito1, Shin-Ichiro Miura1, Kohei Takada1, Rie Koyoshi1, Joji Morii1, Makoto Sugihara1, Ken Mori1, Atsushi Iwata1, Hideto Sako1, Hiroaki Nishikawa1, Akira Kawamura1, Keijiro Saku1.   

Abstract

A 55-year-old man with severe chest pain was hospitalized for acute coronary syndrome. Coronary angiography revealed total occlusion of his left anterior descending coronary artery, which was successfully recanalized by percutaneous coronary intervention (PCI). However, the patient subsequently experienced subacute stent thrombosis, restenosis in the stent, and frequent thrombosis in PCI toward restenosis. Primary antiphospholipid syndrome should be considered as a possible cause of repeated stent thrombosis, and, if salvage by PCI is impossible, salvage by coronary artery bypass graft should be considered.

Entities:  

Keywords:  Acute coronary syndrome; Antiphospholipid syndrome; In-stent restenosis; Percutaneous coronary intervention; Stent thrombosis

Year:  2011        PMID: 30532875      PMCID: PMC6265084          DOI: 10.1016/j.jccase.2011.06.006

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  12 in total

1.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

2.  Dilemma of drug-eluting stent implantation in a patient with systemic lupus erythematosus.

Authors:  Chi-Hang Lee; Mark Y Chan
Journal:  Int J Cardiol       Date:  2006-11-03       Impact factor: 4.164

3.  Multiple early percutaneous transluminal coronary angioplasty failures related to lupus anticoagulant.

Authors:  J D Chambers; H D Haire; U Deligonul
Journal:  Am Heart J       Date:  1996-07       Impact factor: 4.749

4.  Antiphospholipid syndrome: long-time research on pathogenic mechanisms has finally lead to new therapeutic strategies.

Authors:  Ricard Cervera; Gerard Espinosa
Journal:  Expert Opin Ther Targets       Date:  2010-12       Impact factor: 6.902

5.  Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Jean-Charles Piette; Josep Font; Munther A Khamashta; Yehuda Shoenfeld; María Teresa Camps; Soren Jacobsen; Gabriella Lakos; Angela Tincani; Irene Kontopoulou-Griva; Mauro Galeazzi; Pier Luigi Meroni; Ronald H W M Derksen; Philip G de Groot; Erika Gromnica-Ihle; Marta Baleva; Marta Mosca; Stefano Bombardieri; Frédéric Houssiau; Jean-Christophe Gris; Isabelle Quéré; Eric Hachulla; Carlos Vasconcelos; Beate Roch; Antonio Fernández-Nebro; Marie-Claire Boffa; Graham R V Hughes; Miguel Ingelmo
Journal:  Arthritis Rheum       Date:  2002-04

6.  Antiphospholipid syndrome in cardiac surgery-an underestimated coagulation disorder?

Authors:  Parwis Massoudy; Sürreya M Cetin; Matthias Thielmann; P Kienbaum; Jarowit A Piotrowski; Günter Marggraf; Christof Specker; Heinz Jakob
Journal:  Eur J Cardiothorac Surg       Date:  2005-02-24       Impact factor: 4.191

7.  Reduction of atherosclerosis in low-density lipoprotein receptor-deficient mice by passive administration of antiphospholipid antibody.

Authors:  Danielle Nicolo; Bruce I Goldman; Marc Monestier
Journal:  Arthritis Rheum       Date:  2003-10

8.  A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

Authors:  M B Leon; D S Baim; J J Popma; P C Gordon; D E Cutlip; K K Ho; A Giambartolomei; D J Diver; D M Lasorda; D O Williams; S J Pocock; R E Kuntz
Journal:  N Engl J Med       Date:  1998-12-03       Impact factor: 91.245

9.  Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure.

Authors:  A Schömig; A Kastrati; H Mudra; R Blasini; H Schühlen; V Klauss; G Richardt; F J Neumann
Journal:  Circulation       Date:  1994-12       Impact factor: 29.690

10.  Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation.

Authors:  Takeshi Kimura; Takeshi Morimoto; Yoshihisa Nakagawa; Toshihiro Tamura; Kazushige Kadota; Hitoshi Yasumoto; Hideo Nishikawa; Yoshikazu Hiasa; Toshiya Muramatsu; Taiichiro Meguro; Naoto Inoue; Hidehiko Honda; Yasuhiko Hayashi; Shunichi Miyazaki; Shigeru Oshima; Takashi Honda; Nobuo Shiode; Masanobu Namura; Takahito Sone; Masakiyo Nobuyoshi; Toru Kita; Kazuaki Mitsudo
Journal:  Circulation       Date:  2009-02-09       Impact factor: 29.690

View more
  2 in total

1.  Therapeutic challenges after successful thrombectomy in a patient with an antiphospholipid syndrome associated M1-occlusion: A case report.

Authors:  Katharina Stadler; Johannes S Mutzenbach; Gudrun Kalss; Johann Sellner; Abdul R Al-Schameri; Eugen Trinka; Monika Killer-Oberpfalzer
Journal:  Interv Neuroradiol       Date:  2015-07-01       Impact factor: 1.610

2.  Antiphospholipid syndrome and valvular heart disease, a complex scenario of thrombotic events, a case report.

Authors:  Santiago A Endara; Gerardo A Dávalos; Christian H Fierro; Vladimir E Ullauri; Gabriel A Molina
Journal:  J Cardiothorac Surg       Date:  2020-09-29       Impact factor: 1.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.